NCT00608179View on ClinicalTrials.gov

Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2004

Study Completion Date

December 31, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

Glimepiride

Glimepiride (Amaryl) 4 mg oral dose during protocol, given once during each protocol.

DRUG

glyburide

Glyburide (Dia-Beta) 10 mg oral dose during protocol, given once during each protocol.

OTHER

glucose clamp

Hyperinsulinemic euglycemic glucose clamp procedure-120 minutes

OTHER

glucose clamp

hypoglycemic glucose clamp procedure -120 minutes

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00608179 - Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia | Biotech Hunter | Biotech Hunter